Raymond James & Associates Trillium Therapeutics Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
N/A
-42,037 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
N/A
6,131 Added 17.08%
42,037 $738,000
Q2 2021

Aug 11, 2021
BUY
N/A
1,424 Added 4.13%
35,906 $348,000
Q1 2021

May 14, 2021
BUY
N/A
20,885 Added 153.6%
34,482 $370,000
Q4 2020

Feb 12, 2021
BUY
N/A
13,597 New
13,597 $200,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email